139 related articles for article (PubMed ID: 26382626)
1. Clinical Usefulness of Serum Krebs von den Lungen-6 for Detecting Chronic Aspiration in Children with Severe Motor and Intellectual Disabilities.
Wakamoto H; Sano N; Yano Y; Sakai S; Kikuchi T; Fukuda M; Morimoto T; Ishii E
J Pediatr; 2015 Nov; 167(5):1136-42. PubMed ID: 26382626
[TBL] [Abstract][Full Text] [Related]
2. KL-6 as a biomarker of respiratory complications in severely disabled children.
Ochi F; Fukuda M; Ohmori H; Yano Y; Wakamoto H; Suzuki Y; Ishii E
Pediatr Int; 2015 Jun; 57(3):439-42. PubMed ID: 25405273
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Value of Krebs von den Lungen (KL-6) for Interstitial Lung Disease: A European Prospective Cohort.
Millan-Billi P; Castellví I; Martinez-Martinez L; Mariscal A; Barril S; D'Alessandro M; Franquet T; Castillo D
Arch Bronconeumol; 2024 Jun; 60(6):350-355. PubMed ID: 38644152
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of monitoring the circulating Krebs von den Lungen-6 levels to predict the clinical outcome of patients with advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.
Ishikawa N; Hattori N; Yokoyama A; Tanaka S; Nishino R; Yoshioka K; Ohshimo S; Fujitaka K; Ohnishi H; Hamada H; Arihiro K; Kohno N
Int J Cancer; 2008 Jun; 122(11):2612-20. PubMed ID: 18324627
[TBL] [Abstract][Full Text] [Related]
5. Serum Krebs Von Den Lungen-6 as a Biomarker for Early Detection of Bronchiolitis Obliterans Syndrome in Children Undergoing Allogeneic Stem Cell Transplantation.
Gassas A; Schechter T; Krueger J; Craig-Barnes H; Sung L; Ali M; Dell S; Egeler RM; Zaidman I; Palaniyar N
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1524-8. PubMed ID: 25963919
[TBL] [Abstract][Full Text] [Related]
6. Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer.
Tanaka S; Hattori N; Ishikawa N; Shoda H; Takano A; Nishino R; Okada M; Arihiro K; Inai K; Hamada H; Yokoyama A; Kohno N
Int J Cancer; 2012 Jan; 130(2):377-87. PubMed ID: 21351094
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of serum Krebs von den Lungen-6 for the management of myositis-associated interstitial lung disease.
Takanashi S; Nishina N; Nakazawa M; Kaneko Y; Takeuchi T
Rheumatology (Oxford); 2019 Jun; 58(6):1034-1039. PubMed ID: 30624752
[TBL] [Abstract][Full Text] [Related]
8. Krebs von den Lungen-6 associated with chest high-resolution CT score in evaluation severity of patients with interstitial lung disease.
Qin H; Xu XP; Zou J; Zhao XJ; Wu HW; Zha QF; Chen S; Kang Y; Jiang HD
Pulmonology; 2019; 25(3):143-148. PubMed ID: 30007895
[TBL] [Abstract][Full Text] [Related]
9. SP-D, KL-6, and HTI-56 levels in children with mycoplasma pneumoniae pneumonia.
Shu LH; Lu Q; Han LY; Dong GH
Int J Clin Exp Pathol; 2015; 8(9):11185-91. PubMed ID: 26617840
[TBL] [Abstract][Full Text] [Related]
10. The Value of Biomarkers as Predictors of Outcome in Patients with Rheumatoid Arthritis-Associated Usual Interstitial Pneumonia.
Lee YS; Kim HC; Lee BY; Lee CK; Kim MY; Jang SJ; Lee HS; Moon J; Colby TV; Kim DS
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):216-223. PubMed ID: 27758986
[TBL] [Abstract][Full Text] [Related]
11. Elevated Serum Krebs von den Lungen-6 in Early Disease Predicts Subsequent Deterioration of Pulmonary Function in Patients with Systemic Sclerosis and Interstitial Lung Disease.
Kuwana M; Shirai Y; Takeuchi T
J Rheumatol; 2016 Oct; 43(10):1825-1831. PubMed ID: 27481907
[TBL] [Abstract][Full Text] [Related]
12. Plasma Krebs von den Lungen glycoprotein, lung injury, and noninvasive ventilation in Duchenne muscular dystrophy.
Hamada S; Ishikawa Y; Aoyagi T; Ishikawa Y; Minami R; Bach JR
Am J Phys Med Rehabil; 2012 Oct; 91(10):831-5. PubMed ID: 22760105
[TBL] [Abstract][Full Text] [Related]
13. Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases.
Ishikawa N; Hattori N; Yokoyama A; Kohno N
Respir Investig; 2012 Mar; 50(1):3-13. PubMed ID: 22554854
[TBL] [Abstract][Full Text] [Related]
14. Potential of Krebs von den Lungen-6 as a predictor of relapse in interstitial pneumonia with anti-aminoacyl tRNA synthetase antibodies-positive dermatomyositis.
Isoda K; Kotani T; Takeuchi T; Konma J; Ishida T; Hata K; Otani K; Fujiwara H; Shoda T; Makino S; Arawaka S
Clin Respir J; 2018 Jul; 12(7):2235-2241. PubMed ID: 29633527
[TBL] [Abstract][Full Text] [Related]
15. [The diagnostic value of serum KL-6 in connective tissue disease associated interstitial lung disease].
Wu X; Wu LJ; Luo CN; Shi YM; Zou JM; Meng XY
Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(40):3172-3175. PubMed ID: 31694110
[No Abstract] [Full Text] [Related]
16. Serum KL-6 level is a useful biomarker for evaluating the severity of coronavirus disease 2019.
Awano N; Inomata M; Kuse N; Tone M; Takada K; Muto Y; Fujimoto K; Akagi Y; Mawatari M; Ueda A; Izumo T
Respir Investig; 2020 Nov; 58(6):440-447. PubMed ID: 32863199
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the clinical performance of the HISCL-5000 analyzer in the detection of Krebs von den Lungen-6 antigen and its diagnostic value in interstitial lung disease.
Wang J; Huang Z; Xue M; Huang H; Zheng X; Zhong N; Sun B
J Clin Lab Anal; 2020 Feb; 34(2):e23070. PubMed ID: 31691368
[TBL] [Abstract][Full Text] [Related]
18. [Immunohistochemical Analysis of Krebs von den Lungen-6 (KL-6) Expression in Lung Tissue in Primary Lung Cancer Patients with High Serum KL-6 Levels].
Yatsuyanagi E; Sato K; Sato K
Kyobu Geka; 2015 Sep; 68(10):815-9. PubMed ID: 26329623
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics classified by the serum KL-6 level in patients with organizing pneumonia.
Yamaguchi K; Tsushima K; Kurita N; Fujiwara A; Soeda S; Yamaguchi A; Sugiyama S; Togashi Y; Kono Y; Kasagi S; Setoguchi Y
Sarcoidosis Vasc Diffuse Lung Dis; 2013 Mar; 30(1):43-51. PubMed ID: 24003534
[TBL] [Abstract][Full Text] [Related]
20. Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case-control study.
Xue C; Wu N; Li X; Qiu M; Du X; Ye Q
BMC Pulm Med; 2017 Nov; 17(1):144. PubMed ID: 29149883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
